The Wistar Institute
3601 Spruce Street
Philadelphia
Pennsylvania
19104-4268
United States
Tel: 215-898-3700
Website: http://www.wistar.upenn.edu/
Email: contact@wistar.upenn.edu
45 articles about The Wistar Institute
-
"New" Human Adenovirus May Not Make for Good Vaccines, After All AdHu26 Demonstrates Same Fault as Previously Studied Vaccine Vectors, The Wistar Institute Study
8/12/2010
-
Gene Alteration Enables Mice To Rapidly Heal Wounds, The Wistar Institute Study
3/30/2010
-
One Gene Lost = One Limb Regained? The Wistar Institute Scientists Demonstrate Mammalian Regeneration Through a Single Gene Deletion
3/16/2010
-
Nikon Instruments Inc. And The Wistar Institute Present Small World Exhibition And Microscopy Seminars
1/20/2010
-
Gene That Regulates Breast Cancer Metastasis Identified At The Wistar Institute
10/7/2009
-
Scientists At The Wistar Institute Identify Novel Inhibitor Of Human MicroRNA
9/26/2008
-
Researchers at The Wistar Institute Invigorate 'Exhausted' Immune Cells
9/19/2008
-
The Wistar Institute Receives CEO Cancer Gold StandardTM Accreditation
9/18/2008
-
The Wistar Institute Cracks A Cancer Mystery; Cracking Enzyme Code Opens Way To New Cancer Drugs
9/2/2008
-
Novel Enzyme Inhibitor Paves Way For New Cancer Drug: Agent Proves Effective Against Melanoma Cells, The Wistar Institute Study
5/19/2008
-
Novel Enzyme Inhibitor Paves Way For New Cancer Drug, The Wistar Institute Study
5/16/2008
-
Structure Of Gene Regulator That Plays Key Role In Cancer Solved, The Wistar Institute Study
2/14/2008
-
Novel Vaccine Concept Developed By Scientists At The Wistar Institute
1/31/2008
-
Virus Used to Create Experimental HIV Vaccines Directly Impairs the Immune Response, The Wistar Institute Study
11/16/2007
-
Telomerase Enzyme Structure Provides Significant New Target for Anti-Cancer Therapies, The Wistar Institute Study
11/16/2007
-
The Wistar Institute's Study: Immune Cells Fighting Chronic Infections Become Progressively 'Exhausted' Ineffective: Potential Interventions to Restore Disease-Fighting Capability Outlined
10/19/2007
-
Newly Identified Mechanism for Silencing Genes Points to Possible Anti-Cancer Strategies, The Wistar Institute Study
5/17/2007
-
Novel Antigen-Cloning Technique may Boost Efforts to Develop a Melanoma Vaccine, The Wistar Institute Study Finds
4/16/2007
-
Gene-Regulating Enzyme Is Also A Target For Anti-Depressive Drugs
6/26/2006
-
The Wistar Institute Sells Partial Royalty Interest In Merck & Co., Inc.'s ROTATEQ(R) To The Paul Royalty Fund
12/15/2005